VERU INC. Income Taxes Receivable, Current
VERU INC. (VERU) had Income Taxes Receivable, Current of $37.10 thousand as of 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Notes › and Others › Nontrade Receivables
us-gaap:IncomeTaxesReceivable · last filed 2018-01-02
- 2017-06-30: Income Taxes Receivable, Current $37.10K.
- 2017-03-31: Income Taxes Receivable, Current $2.23K.
- 2016-12-31: Income Taxes Receivable, Current $2.20K.
- 2016-09-30: Income Taxes Receivable, Current $2.39K.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2017-06-30 | $37.10K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $2.23K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $2.20K 10-Q · filed 2017-02-09 |
| 2016-09-30 | $2.39K 10-K · filed 2018-01-02 |
| 2016-06-30 | $29.00K 10-Q · filed 2016-07-28 |
| 2016-03-31 | $29.70K 10-Q · filed 2016-04-28 |
| 2015-12-31 | $27.20K 10-Q · filed 2016-02-02 |
| 2015-09-30 | $21.25K 10-K · filed 2016-12-12 |
| 2014-06-30 | $78.04K 10-Q · filed 2014-07-31 |
| 2014-03-31 | $160.61K 10-Q · filed 2014-05-01 |
| 2013-12-31 | $77.52K 10-Q · filed 2014-02-03 |
| 2013-09-30 | $78.44K 10-K · filed 2014-12-02 |
| 2013-03-31 | $28.38K 10-Q · filed 2013-05-02 |
| 2012-12-31 | $28.44K 10-Q · filed 2013-01-30 |
| 2012-09-30 | $27.37K 10-K · filed 2013-12-03 |
| 2011-06-30 | $28.56K 10-Q · filed 2011-08-05 |
| 2010-09-30 | $28.18K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |